[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NZ238783A - Carrier; pharmaceutical powder between fibres of a velvet or velour-like material - Google Patents

Carrier; pharmaceutical powder between fibres of a velvet or velour-like material

Info

Publication number
NZ238783A
NZ238783A NZ238783A NZ23878391A NZ238783A NZ 238783 A NZ238783 A NZ 238783A NZ 238783 A NZ238783 A NZ 238783A NZ 23878391 A NZ23878391 A NZ 23878391A NZ 238783 A NZ238783 A NZ 238783A
Authority
NZ
New Zealand
Prior art keywords
powder
carrier
charged
fibres
suspension
Prior art date
Application number
NZ238783A
Inventor
Arun R Gupte
Dieter Hochrainer
Gerhard Poss
Juergen Wittekind
Bernd Zierenberg
Adolf Knecht
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4020571A external-priority patent/DE4020571A1/en
Priority claimed from DE19914102793 external-priority patent/DE4102793A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NZ238783A publication Critical patent/NZ238783A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0051Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003Filling medical containers such as ampoules, vials, syringes or the like
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/26Methods or devices for controlling the quantity of the material fed or filled
    • B65B3/34Methods or devices for controlling the quantity of the material fed or filled by timing of filling operations
    • B65B3/36Methods or devices for controlling the quantity of the material fed or filled by timing of filling operations and arresting flow by cut-off means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0225Carbon oxides, e.g. Carbon dioxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/07General characteristics of the apparatus having air pumping means
    • A61M2205/071General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/073Syringe, piston type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/07General characteristics of the apparatus having air pumping means
    • A61M2205/071General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/075Bulb type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/82Internal energy supply devices
    • A61M2205/8218Gas operated
    • A61M2205/8225Gas operated using incorporated gas cartridges for the driving gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Holding Or Fastening Of Disk On Rotational Shaft (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Nozzles (AREA)
  • Electrostatic Spraying Apparatus (AREA)
  • Basic Packing Technique (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Refuse Collection And Transfer (AREA)
  • Disintegrating Or Milling (AREA)
  • Vending Machines For Individual Products (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

In order to produce an aerosol, a velvety or velours-like material charged with a powder is brought into an air current.

Description

<div class="application article clearfix" id="description"> <p class="printTableText" lang="en">2 3 8 7 <br><br> Priori!-, .7rK\^:.f'.P. <br><br> Curri^.uV-; C-;-c::.!i cation r. <br><br> ri*o&lt;,; <br><br> 27si?'m <br><br> Publication Date: <br><br> P.O. Journal, No: i3&amp;V* <br><br> Patents Form No. 5 <br><br> NEW ZEALAND PATENTS ACT 1953 COMPLETE SPECIFICATION <br><br> APPARATUS AND PROCESS FOR METERING POWDER <br><br> WE, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, a company under the laws of the FEDERAL REPUBLIC OF GERMANY of D-6507 Ingelheim am Rhein, FEDERAL REPUBLIC OF GERMANY <br><br> hereby declare the invention, for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement: <br><br> - 1 - <br><br> (followed by page la) <br><br> - la - <br><br> 86.56831 .333 <br><br> Apparatus and process for metering powder <br><br> 5 The invention relates to an apparatus and a process for metering small amounts of finely divided powder. <br><br> Small amounts of finely divided, preferably micronised powder are used in particular, for therapeutic purposes, mainly in aerosol formulations for 10 the treatment by inhalation of respiratory complaints such as asthma. <br><br> Powders of this kind are conveyed to the patient's lungs in amounts which are usually well below 50 mg per inhalation. It has been found that the particles of 15 active substance should be less than 10 ^m in size to ensure that they penetrate deep into the lungs. <br><br> However, this does not rule out the use of some larger particles in the preparations, particularly for any excipients. If particles of different sizes are used, a 20 significant difference in size is sometimes even desirable or is in any case not harmful; see for example US 3 860 618. <br><br> Two main methods have been developed as alternatives for administering fine powders without the 2 5 aid of propellant gases in respiratory tract therapy. <br><br> One method makes use of hard gelatine capsules each of which contains a dose of active substance and possibly also excipients, whilst the other, using a measuring chamber, removes a specific amount of powder 30 from a storage container and mixes it with the air breathed in. Devices for both methods have been described in large numbers, see for example NZ 175 387 and EP-A 166 294. <br><br> The present invention now provides a-new method of 35 administering fine powders. In our method, the ease of manufacture of carriers charged with active substance is advantageously combined with accuracy of metering and <br><br> /''' " <br><br> (followed by page 2) <br><br> 2 <br><br> the possibility of producing an aerosol suitable for inhalation by simple means. <br><br> According to the invention, a velour or velvet-like carrier material is charged with powder which is to be 5 metered and the desired amount of powder is blown from the carrier material by means of a gas jet, optionally after mechanical loosening, preferably using an air jet of suitable intensity. When used for inhalation, the powder released is mixed with the air to be inhaled, 10 optionally via an inhalation device such as the one described for example in US 4 174 712. <br><br> When the dry powder is spread into the velour material, the movement of the fibres under the doctor blade causes a preliminary break-up. The particles are 15 then in a very loose state and are correspondingly less inclined to clump together. When the powder is applied by means of a suspension, this preliminary break-up is achieved by running an edge over the powder, so that once again only some of the energy for the breaking-up 20 has to be supplied by the gas jet. Moreover, the previously broken up particles present a large surface area for contact with the gas jet, which again has a favourable effect on dispersal. <br><br> 25 material on which thin fibres are provided. The fibres carrier, the free end or the two free ends being directed upwardly and the carrier and fibres predominantly forming angles of 45 to 90°, more <br><br> 30 particularly 60 to 90° with one another. The material which carries the fibres may be, for example, paper, plastics film or a textile fabric; the fibres may be natural or synthetic, e.g. cotton, wool, silk, viscose, perlon, nylon or polyacrylic. <br><br> 35 The fibres are generally up to about 3 mm long, <br><br> preferably up to about 1 mm long. They should not be too matted, so as to try and ensure that the powder <br><br> The carrier comprises a substantially planar are secured at one end or at their centre on or in the <br><br> 23 87 8 3 <br><br> - 3 - <br><br> applied, which is essentially situated or embedded between the fibres, can be blown out again relatively easily. The lower limit for the length of the fibres is about 0.1 mm. Generally, the length of the fibres 5 should be such that the powder applied can be accommodated in the desired quantities per unit of surface area. <br><br> Accordingly, a carrier material with longer fibres may be appropriate for relatively large quantities of 10 powder per unit of surface area, whereas, for very small quantities of powder per unit of surface area, shorter fibres are usable or, even, advantageous. The quantity of powder which can be applied per unit of surface area depends mainly on the nature (density) of the powder and 15 its compaction, as well as the carrier material used. <br><br> If the powder is to be administered by inhalation, care must however be taken to ensure that the dispersal of the powder in the gas or air jet used is not affected by excessive compaction. <br><br> 2 0 The number of fibres per unit of surface area may vary considerably. Various commercially available carriers have proved suitable (velour-film, velvet, nicki). These products also provide a guide to the suitable fibre density of other carriers. The fibre 25 thickness also varies within wide limits. Generally, <br><br> fibres with a diameter of from 0.002 to 0.05, preferably 0.004 to 0.03 mm are used. The velvet-like carrier itself may also be attached, e.g. by glueing, to a stiff layer. It is also possible to attach an absorbent <br><br> 3 0 under-layer. <br><br> The carrier may therefore be flexible or rigid and of any desired shape, rectangular or circular for example. Preferably, the carrier is in the form of a strip. This may be charged with the powder over its 35 entire surface or over individual areas. In the latter case, the strip may be charged with the powder by means of a template over small individual areas, e.g. in the <br><br> 23 8 ? <br><br> - 4 - <br><br> form of circular areas a few millimetres in diameter and clearly spaced apart, so that when the powder is blown out from one of these areas the powder on the neighbouring areas remains unaffected. <br><br> 5 Thus, the dose can be accurately fixed by means of the quantity of powder on each of the small charged areas. <br><br> If the entire surface of the carrier is coated with powder, the quantity of powder which is blown out can 10 simply be determined by the size of the area exposed to the gas jet during each separate removal operation and defined, for example, by means of a mask. However, a mask is not essential. It has been found, in fact, that the quantity of powder blown downwards from the 15 uniformly charged carrier by means of the gas jet is substantially constant. Consequently, the quantity of powder dispersed can be readily regulated by the intensity of the gas jet and the geometry of the nozzle. <br><br> In order to protect the layer of powder it may be 20 appropriate to cover or laminate the carrier with a plastics film, for example, in such a way that only that part of the carrier from which powder is to be taken is exposed. Particularly in the case of moisture-sensitive powders, an aluminium lamination on both sides might be 25 considered. Finally, it is also possible to use carriers, e.g. strips, in which there are alternating areas filled with fibres and smooth areas. <br><br> According to a further feature of the invention, we provide a process for producing a carrier as described 30 above in which the powder is uniformly distributed on the carrier and is incorporated in the fibre layer in one or more steps using a doctor blade or the powder is applied to the velvet- or velour-like carrier in the form of a small amount of a suspension and the 35 suspending agent is evaporated off. <br><br> In order to charge the carrier using one embodiment, first of all a layer of powder 1 to 2 mm <br><br> 2387 83 <br><br> - 5 - <br><br> high is distributed as uniformly as possible thereon (in the case of highly effective pharmaceutical powders and in the case of carriers with very short fibres the layer may be considerably thinner). The powder is pressed 5 into the strip by means of a doctor blade and excess powder is wiped away. This process is repeated once or several times, as necessary, with the doctor blade being set progressively lower. As a result of the movement of the fibres under the pressure of the doctor blade, the 10 agglomerated areas of powder are broken up. <br><br> If only certain parts of the carrier are to be charged, the carrier may be covered, for example, with a template, e.g. a suitably perforated film. If the powder is then applied as described above, the carrier 15 will be charged with it only at those points where the perforations are located. <br><br> In another embodiment, the powder may also be applied to the carrier in the form of a suspension. In the case of pharmaceutical compositions for inhalation, 20 the dosage of active substance is generally so small that the quantity of active substance contained in one drop of suspension is sufficient. One drop of the suspension is then applied at the desired spacing from the next drop. The spacing is selected so that the spot 25 of powder which remains after evaporation of the suspension agent is clearly separated from the adjacent spot. The aim is to be able to separate only the exact quantity of powder applied in one drop from the carrier when the powdered active substance is transferred into 30 the stream of air inhaled. <br><br> It is particularly satisfactory to charge the carrier with an accurately metered quantity of powder over a small area using a suspension. <br><br> The suspending agents used may be liquid organic 35 compounds in which the powder to be applied does not dissolve readily and which can be eliminated as completely as possible. <br><br> 238783 <br><br> - 6 - <br><br> Examples of suspending agents of this kind which are selected in accordance with the solubility characteristics of the substance or mixture of substances to be suspended include dichloromethane, 5 ethyl acetate, 1,1,1-trichloroethane or petrol (e.g. the fraction 60/95 or 80/110). As a rule, suspension adjuvants such as lecithin are added to the suspension. The solids content in the suspension is usually between 3 and 30 percent by weight, preferably from 5 to 25 10 percent by weight; the quantity of suspension adjuvants varies between about 0.5 and 3 percent by weight, based on the solids. <br><br> The carriers and suspension should be such that the particles of powder are left behind at the point where 15 the drop penetrates into the carrier, whilst the suspending agent spreads out and then evaporates. The evaporation can be promoted by pressure reduction and/or by heating. <br><br> The material from the dried drop of suspension 20 cannot generally be released and dispersed simply by means of a jet of air. However, if the fibres of the carrier are moved, e.g. by running an edge over them the bonds between the particles of powder are broken up again and the powder is "activated". The individual 25 particles which adhere to one another or to the fibres of the carrier with only slight adhesive force after activation can then be released by means of an air jet and dispersed, to a large extent, into the lungs. <br><br> Instead of releasing the loosened powder from the 30 carrier by means of a jet of air, it is also possible to loosen it by running an edge over it or by brushing, immediately before or while the flow of breathed-in air is passing the carrier, and thereby transferring the powder into the air which is breathed in. <br><br> 35 Apart from the high degree of accuracy of metering, <br><br> the application of a drop of suspension has the further advantage over the application of dry powder that the <br><br> 238783 <br><br> - 7 - <br><br> powder is protected from being released by acceleration (impact, vibrations) by the incrustation. The activation by running along an edge should only be carried out immediately before the powder is released 5 for inhalation. <br><br> The invention may be more particularly understood with reference to the accompanying drawings. These are by way of example only and in the drawings: <br><br> Figure 1 shows diagrammatically an apparatus 10 according to the invention for applying the drop of suspension; <br><br> In Figure 2 shows cross-section of part of an electronic valve represented in Figure 1. <br><br> Figures 3 and 4 show diagrammatically front and 15 side views of a simple device in which carriers charged according to the invention may be used. <br><br> In Figure 1, suspension 1 is initially in storage container 2. From there it flows through line 3 to a magnetic valve 4 and passed the valve surfaces through 20 line 5 into storage container 6. Details of the magnetic valve are illustrated in Figure 2. In the resting position plunger 7 seals off the inlet port of line 8 from which the suspension is applied to carrier 11. At or around the sides, the suspension is able to 25 flow past the plunger from the line 3 to the line 5. <br><br> When the plunger is pulled back by an electromagnet, it exposes the opening so that the suspension can reach the carrier 11. The suspension is pumped out of the container 6 by means of pump 9 into the storage 30 container 2. To ensure that the suspension in storage container 2 is always at the same level, there is a connecting line 10 between these two storage containers, through which suspension can flow from storage container 2 into storage container 6 when the liquid level is 35 higher than the entry port of this connecting line. The cross-section of the lines 3 and 10 is made so small that the volume flow of suspension flowing through the <br><br> 23 8 7 8 <br><br> - 8 - <br><br> two lines is less than the volume flow delivered by the pump 9. In the storage containers 2 and 6 are stirrers which keep the particles constantly suspended. For uniform metering, the magnetic valve 4 is controlled by 5 an electronic timer (not shown). <br><br> A simple device in which carriers charged according to the invention can be used is diagrammatically shown in Figures 3 and 4. The main constituents are two bobbins, one of which receives the charged strip whilst 10 the other' receives the used strip. The strip is guided over a panel, whilst being guided passed an edge to . activate the powder. Here, the jet of gas or air makes contact with the strip and carries the powder along. The jet is generally released at a time when air is 15 being breathed in through the mouthpiece. It is advisable to actuate the stream of gas or air by means of the air breathed in so as to coordinate the dispersal of the powder with the inhalation of the process. <br><br> Figure 3 shows an inhalation device viewed from in 20 front. A carrier strip 12 with the powder, which is applied in individual dots at regular intervals on the strip, is unwound from bobbin 13 and, once empty, wound onto bobbin 14. By means of a transporting mechanism constructed in conventional manner, the strip is wound 25 on, on each actuation of the device, by an amount such that a new spot arrives on flat surface 15. The flat surface 15 is located in a mouthpiece 16 through which the patient inhales. The slot through which the carrier strip 12 is guided into the mouthpiece is somewhat 30 narrower than the thickness of the carrier strip 12. <br><br> The upper boundary of the slot is constructed as an edge for activating the powder. Air is passed onto the dot of powder through a nozzle 21 from a cylinder 17 in which there is a piston subjected to spring pressure 35 with a handle 18. The spring which urges the piston towards the flat surface 15 is biased by pulling the handle 18. The dispersing step is prepared by means of <br><br> 23 87 <br><br> - 9 - <br><br> a locking mechanism 19 which can be released by pressing knob 20. Whilst breathing in through the mouthpiece 16 the patient presses the knob 20 and thus ensures that the piston propels the quantity of air contained in the cylinder through the nozzle onto the dot of powder, so that the powder is dispersed in the air breathed in. <br><br> Figure 4 diagrammatically shows the apparatus from the side, the mouthpiece 16 being shown in section. The nozzle 21 (not shown in Figure 4) guides the jet of air out of the cylinder 17 onto the dot of powder. <br><br> The bobbins with the carrier are in this case contained in a cassette similar to that used in cassette recorders. Their movement is advantageously coupled with the movement of the handle 18, so that, each time the piston is put under tension, the carrying strip is moved on until the next dot reaches the flat surface 15. <br><br> 23 87 <br><br> - 10 - <br><br> Example of the application of the pharmaceutical composition as a suspension: <br><br> A suspension of micronised fenoterol (proportion of fenoterol: 10 percent by weight) in dichloromethane 5 with the addition of (0.1 percent by weight) <br><br> lecithin was applied to velvet with a fibre length of 1.2 mm over the basic fabric, dropwise at spacings of about 10 mm and then dried. The powder was then activated by running an edge over it and 10 blown out of the carrier with a gentle jet of compressed air. <br><br> The inhalable portion of the particles (particle diameter &lt; 5.8 /im) was 41.4% of the dosage expelled. <br><br> 15 <br><br> A relatively small amount of gas, e.g. 10 cc or air, forced through a 0.5 mm diameter nozzle, is sufficient to disperse (blow out) the powder. <br><br> The gas jet required for dispersal can be produced 20 in various ways, e.g. using a cylinder provided with a nozzle out of which air is forced by a spring-operated piston, or by means of conventional small C02 containers which can be used to generate pressure. <br><br> Instead of the cylinder and spring it is also 25 possible to use a bellows or a C02 cartridge of conventional construction which releases a few cc of C02 every time the device is used, in order to generate a gas current, as mentioned above. The C02 is then again guided through a nozzle onto the carrier surface coated 30 with powder. The volume of gas needed to disperse a quantity of powder required for therapeutic purposes is generally 3 to 20 cc (under normal conditions). <br><br> Nozzles are used which have a mouth shaped to suit the type of carrier. In the case of circular dots of 35 powder, the nozzle has a small, preferably circular aperture. In the case of larger, powder-coated carrier surfaces, a slot-shaped or rectangular nozzle may be <br><br> 23 87 8 3 <br><br> - 11 - <br><br> 10 <br><br> more appropriate. In this case, a larger quantity of gas is used, if necessary, in order to ensure the required speed of outflow. <br><br> The accuracy of metering was measured in a series of tests in which either (tests 1, 2, 3) a carrier strip was continuously coated by the application of dry powder and a sharply defined section of the strip was investigated in each case or else a strip was used in which only certain places had a coating of powder. <br><br> The following surface coatings and relative standard deviations were found: <br><br> 15 <br><br> Material <br><br> Surface Relative standard covering deviation <br><br> 20 <br><br> 1. Velour-film <br><br> 2. Velvet <br><br> 3. Nicki <br><br> 4. Velour-film with individual circular dots of powder* <br><br> 6.6 mg/cmz 2.2 mg/cm2 5.4 mg/cm2 <br><br> 2.1 mg/dot <br><br> 6.3% 6.0% 6.2' <br><br> 11.2% <br><br> * When the powder was applied the carrier was covered 25 with a perforated film. The perforations were 4 mm in diameter and spaced 10 to 15 mm apart. By improving the charge, the standard deviation could be reduced still further in subsequent tests. <br><br> For virtually complete dispersal on blowing out the 30 powder, a relatively small amount of gas is sufficient, e.g. 10 cc of air which is forced through a 0.8 mm diameter nozzle (in the case of the dots of powder according to test number 4). Excellent break-up is found. <br><br> 35 As was established by means of the Andersen impactor using micronised fenoterol, 40% of the particles of the dosage expelled were in the particle size range below 5.8 /im. <br><br> 238783 <br><br> WHAT WE CLAIM IS: <br><br> 1. A carrier charged with a powdered pharmaceutical preparation which comprises a substantially flat 5 material on which fibres are arranged in a velvet- or velour-like manner and the powder is incorporated between the fibres. <br><br> 2. A powder-charged carrier as claimed in claim 1, in 10 which the fibre material is 0.1 to 3 mm. <br><br> 3. A powder-charged carrier as claimed in claim 1 or claim 2, in which the material which carries the fibres is flexible. <br><br> 4. A powder-charged carrier as claimed in claim 1 or claim 2, in which the material which carries the fibres is rigid. <br><br> 20 5. A powder-charged carrier as claimed in any one of claims 1 to 4, in which an entire surface of the carrier is uniformly charged with powder. <br><br> 6. A powder-charged carrier as claimed in any one of <br><br></p> </div>

Claims (1)

1. 25 claims 1 to 4, in which areas of the carrier are individually charged with powder, the individual charged areas of the carrier each containing a single dose of a powdered pharmaceutical substance. 30 7. A powder-charged carrier as claimed in any one of claims 1 to 6, in which either a side of the carrier which is powder-charged or both sides of the carrier are provided with a protective film. 35 8. A powder-charged carrier substantially as hereinbefore described and with reference to the Example. 9 . A process f c^rz^^a carrier as claimed in any 28 JUL 1994 _RECE!VJ£~~ 10 - 13 - one of claims 1 to 8, wherein the powder is uniformly-distributed on the carrier and is incorporated in the fibre material in one or more steps using a doctor blade. 10. A process for producing a carrier as claimed in anyone of claims 1 to 8, wherein the powder is applied to the carrier in the form of a small amount of a suspension and the suspending agent is evaporated off. 11. A process as claimed in claim 10 substantially as hereinbefore described and with reference to the Example. 15 12. A process for the production of a carrier as claimed in claim 1 as hereinbefore described with reference to any one of Figures 1-2. 20 BOEHRINGER INGELHEIM INTERNATIONAL GmbH rj.Z.PATGWTOFUCE 8 JUL 1394 ; RBC'dlVTQ-
NZ238783A 1990-06-28 1991-06-28 Carrier; pharmaceutical powder between fibres of a velvet or velour-like material NZ238783A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4020571A DE4020571A1 (en) 1990-06-28 1990-06-28 Device for dosing small quantities of powder esp. for asthma - powder is held between fibres of velvet-like material and is delivered, e.g. as medication into patients inhaled breath, by jet of air
DE19914102793 DE4102793A1 (en) 1991-01-31 1991-01-31 Medication powder-dosing carrier

Publications (1)

Publication Number Publication Date
NZ238783A true NZ238783A (en) 1994-09-27

Family

ID=25894544

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ238783A NZ238783A (en) 1990-06-28 1991-06-28 Carrier; pharmaceutical powder between fibres of a velvet or velour-like material

Country Status (24)

Country Link
EP (1) EP0536232B1 (en)
JP (1) JP3307389B2 (en)
KR (1) KR0179375B1 (en)
AT (1) ATE127353T1 (en)
AU (1) AU661274B2 (en)
CA (1) CA2086123C (en)
CZ (1) CZ283510B6 (en)
DE (1) DE59106431D1 (en)
DK (1) DK0536232T3 (en)
ES (1) ES2078530T3 (en)
FI (1) FI104410B (en)
GR (1) GR3017782T3 (en)
HU (1) HU216129B (en)
IE (1) IE69035B1 (en)
IL (1) IL98637A (en)
NO (1) NO304295B1 (en)
NZ (1) NZ238783A (en)
PL (1) PL165973B1 (en)
PT (1) PT98112B (en)
RU (1) RU2068274C1 (en)
SI (1) SI9111110B (en)
UA (1) UA27765C2 (en)
WO (1) WO1992000115A1 (en)
YU (1) YU48708B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
DE4142238A1 (en) * 1991-12-20 1993-06-24 Boehringer Ingelheim Kg POWDER INHALATOR WITH POWDER SUPPORT FROM REGULAR MICROSTRUCTURES
SE9203570D0 (en) * 1992-11-27 1992-11-27 Astra Ab INHALES FOR MULTIPLE USE
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
DE69516909T2 (en) * 1994-10-21 2000-11-02 Glaxo Wellcome Inc., Research Triangle Park MEDICINAL SUPPORT FOR DRY POWDER INHALER AND METHOD FOR PRODUCING THE SAME
US5647347A (en) * 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
GB9616047D0 (en) 1996-07-31 1996-09-11 Glaxo Group Ltd Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
WO2001094027A2 (en) * 2000-06-05 2001-12-13 Nordson Corporation Apparatus and methods for dispensing minute amounts of liquid
WO2007088425A2 (en) 2005-12-22 2007-08-09 Philip Morris Products S.A. Inhaler device
CN108814979B (en) * 2018-04-17 2020-09-22 吉林省中医药科学院 A solid medicine feed ware for paediatrics
CN113650947B (en) * 2021-08-24 2022-10-18 王霞 Accurate medicine bottle of getting of traditional chinese medicine dripping pill

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2837040C2 (en) * 1978-08-24 1982-10-21 Siemens AG, 1000 Berlin und 8000 München Liquid transport system for an inhalation device
GB8909891D0 (en) * 1989-04-28 1989-06-14 Riker Laboratories Inc Device
DE69034007T2 (en) * 1989-04-28 2003-05-08 Riker Laboratories Inc., Northridge Inhalation device for dry powder

Also Published As

Publication number Publication date
KR930701206A (en) 1993-06-11
HU216129B (en) 1999-04-28
HU9204100D0 (en) 1993-05-28
GR3017782T3 (en) 1996-01-31
CZ283510B6 (en) 1998-04-15
HUT63775A (en) 1993-10-28
YU48708B (en) 1999-07-28
EP0536232A1 (en) 1993-04-14
DE59106431D1 (en) 1995-10-12
FI925882A (en) 1992-12-28
DK0536232T3 (en) 1996-01-22
IL98637A0 (en) 1992-07-15
ATE127353T1 (en) 1995-09-15
NO925010L (en) 1993-01-29
SI9111110B (en) 1999-06-30
FI104410B (en) 2000-01-31
WO1992000115A1 (en) 1992-01-09
IE69035B1 (en) 1996-08-07
CA2086123A1 (en) 1991-12-29
KR0179375B1 (en) 1999-04-01
JPH05508334A (en) 1993-11-25
JP3307389B2 (en) 2002-07-24
YU111091A (en) 1994-11-15
AU661274B2 (en) 1995-07-20
PL165973B1 (en) 1995-03-31
FI925882A0 (en) 1992-12-28
IL98637A (en) 1998-01-04
NO925010D0 (en) 1992-12-23
EP0536232B1 (en) 1995-09-06
IE912245A1 (en) 1992-01-01
UA27765C2 (en) 2000-10-16
CA2086123C (en) 2002-01-01
SI9111110A (en) 1997-02-28
NO304295B1 (en) 1998-11-30
CZ386192A3 (en) 1993-10-13
RU2068274C1 (en) 1996-10-27
AU8063891A (en) 1992-01-23
ES2078530T3 (en) 1995-12-16
PT98112A (en) 1993-09-30
PT98112B (en) 1998-12-31

Similar Documents

Publication Publication Date Title
AU645788B2 (en) Device
CA2086123C (en) Apparatus and process for metering powder
KR0178798B1 (en) Dry powder inhalation device
EP0705614B1 (en) Dry powder inhalation device
US5503869A (en) Process for forming medicament carrier for dry powder inhalator
CA2157584C (en) Dry powder medicament inhalator
DE4020571A1 (en) Device for dosing small quantities of powder esp. for asthma - powder is held between fibres of velvet-like material and is delivered, e.g. as medication into patients inhaled breath, by jet of air
EP0843566B1 (en) Medicament carrier for dry powder inhalator and process for forming the same
DE4102793A1 (en) Medication powder-dosing carrier

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)